TCL Archive FDA advisors vote against recommending Johnson & Johnson’s Zarnestra for treatment of AML in the elderly. May 6, 2005
TCL Archive NCI to Get 43 Out Of 200 New Aids Positions, 15 Others; Roper Says That’s “Fair” November 11, 1988
TCL Archive In Brief: DeVita, Seffrin Head Committee advising Feinstein On National Cancer Revision November 5, 1999
TCL Archive Cancer Genetics Network approved By NCI Advisors, To Start With 8 Centers November 29, 1996
